These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

81 related articles for article (PubMed ID: 15800164)

  • 1. Increase in risperidone plasma level with lamotrigine.
    Bienentreu SD; Kronmüller KT
    Am J Psychiatry; 2005 Apr; 162(4):811-2. PubMed ID: 15800164
    [No Abstract]   [Full Text] [Related]  

  • 2. Risperidone and lamotrigine: no evidence of a drug interaction.
    Castberg I; Spigset O
    J Clin Psychiatry; 2006 Jul; 67(7):1159. PubMed ID: 16889467
    [No Abstract]   [Full Text] [Related]  

  • 3. Increase of risperidone concentration under chlorprothixene comedication--a case report.
    Bader W; Greiner C; Haen E
    Pharmacopsychiatry; 2008 May; 41(3):116-7. PubMed ID: 18484554
    [No Abstract]   [Full Text] [Related]  

  • 4. Effect of adjunctive lamotrigine treatment on the plasma concentrations of clozapine, risperidone and olanzapine in patients with schizophrenia or bipolar disorder.
    Spina E; D'Arrigo C; Migliardi G; Santoro V; Muscatello MR; Micò U; D'Amico G; Perucca E
    Ther Drug Monit; 2006 Oct; 28(5):599-602. PubMed ID: 17038872
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Lamotrigine as add-on therapy in schizophrenia: results of 2 placebo-controlled trials.
    Goff DC; Keefe R; Citrome L; Davy K; Krystal JH; Large C; Thompson TR; Volavka J; Webster EL
    J Clin Psychopharmacol; 2007 Dec; 27(6):582-9. PubMed ID: 18004124
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Carbamazepine and/or fluvoxamine drug interaction with risperidone in a patient on multiple psychotropic medications.
    Alfaro CL; Nicolson R; Lenane M; Rapoport JL
    Ann Pharmacother; 2000 Jan; 34(1):122-3. PubMed ID: 10669197
    [No Abstract]   [Full Text] [Related]  

  • 7. Risperidone in schizophrenia: is there a role for therapeutic drug monitoring?
    Seto K; Dumontet J; Ensom MH
    Ther Drug Monit; 2011 Jun; 33(3):275-83. PubMed ID: 21436762
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Elevated clozapine plasma level with lamotrigine.
    Kossen M; Selten JP; Kahn RS
    Am J Psychiatry; 2001 Nov; 158(11):1930. PubMed ID: 11691709
    [No Abstract]   [Full Text] [Related]  

  • 9. An importance of dose in antipsychotic combination therapy for schizophrenia.
    Suzuki T
    J Clin Psychopharmacol; 2011 Jun; 31(3):399; author reply 399-400. PubMed ID: 21532376
    [No Abstract]   [Full Text] [Related]  

  • 10. Placebo-controlled trial of lamotrigine added to conventional and atypical antipsychotics in schizophrenia.
    Kremer I; Vass A; Gorelik I; Bar G; Blanaru M; Javitt DC; Heresco-Levy U
    Biol Psychiatry; 2004 Sep; 56(6):441-6. PubMed ID: 15364042
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clinical significance of a CYP2D6 poor metabolizer--a patient with schizophrenia on risperidone treatment.
    Bozina N; Jovanović N; Lovrić M; Medved V
    Ther Drug Monit; 2008 Dec; 30(6):748-51. PubMed ID: 18806696
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Lamotrigine--clozapine combination in refractory schizophrenia: three cases.
    Saba G; Dumortier G; Kalalou K; Benadhira R; Degrassat K; Glikman J; Januel D
    J Neuropsychiatry Clin Neurosci; 2002; 14(1):86. PubMed ID: 11884664
    [No Abstract]   [Full Text] [Related]  

  • 13. Clinical response to risperidone in relation to plasma drug concentrations in acutely exacerbated schizophrenic patients.
    Yasui-Furukori N; Saito M; Nakagami T; Furukori H; Suzuki A; Kondo T; Kaneko S
    J Psychopharmacol; 2010 Jul; 24(7):987-94. PubMed ID: 19477882
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Interpreting serum risperidone concentrations.
    Boerth JM; Caley CF; Goethe JW
    Pharmacotherapy; 2005 Feb; 25(2):299-302. PubMed ID: 15767244
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Inhibition of risperidone metabolism by fluoxetine in patients with schizophrenia: a clinically relevant pharmacokinetic drug interaction.
    Spina E; Avenoso A; Scordo MG; Ancione M; Madia A; Gatti G; Perucca E
    J Clin Psychopharmacol; 2002 Aug; 22(4):419-23. PubMed ID: 12172343
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pharmacokinetic drug-drug interactions between olanzapine and valproate need to be better studied.
    de Leon J; Diaz FJ; Spina E
    J Clin Psychiatry; 2010 Jul; 71(7):957-8; author reply 958-9. PubMed ID: 20667295
    [No Abstract]   [Full Text] [Related]  

  • 17. Serum concentrations and clinical effects of risperidone in schizophrenic patients in Singapore--a preliminary report.
    Lee HS; Tan CH; Khoo YM; Chee KT; Wong KE; Chong SA; Mahendran R; Yap JL; Low BL; Choo CH; Chan A
    Br J Clin Pharmacol; 1999 Apr; 47(4):460-1. PubMed ID: 10366241
    [No Abstract]   [Full Text] [Related]  

  • 18. Valproic acid and risperidone: a drug interaction?
    Sund JK; Aamo T; Spigset O
    J Am Acad Child Adolesc Psychiatry; 2003 Jan; 42(1):1-2. PubMed ID: 12500067
    [No Abstract]   [Full Text] [Related]  

  • 19. Carbamazepine-risperidone interactions in patients with epilepsy.
    Mula M; Monaco F
    Clin Neuropharmacol; 2002; 25(2):97-100. PubMed ID: 11981236
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Co-administration of Magnesium Oxide Reduces the Serum Concentration of Hydrophobic Basic Drugs in Patients Treated with Antipsychotic Drugs.
    Yoshida H; Takahashi M; Honda M; Amayasu H; Ando M
    Biol Pharm Bull; 2019; 42(6):1025-1029. PubMed ID: 31155577
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.